Company Profiles

driven by the PitchBook Platform

Ventria Bioscience

Description

Developer of life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases. The company produces medicinal products that are enabled by ExpressTec, a breakthrough in biomanufacturing that is meant to enable global access and affordability. A division of the company makes and sells animal-component-free cell culture reagents and designs animal-component-free cell culture media formulations for cell-based vaccines, cellular therapies and biomanufacturing.

2001

Founded

11-50

Employees

Grant

Latest Deal Type

$731k

Latest Deal Amount

4

Investors

Description

Developer of life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases. The company produces medicinal products that are enabled by ExpressTec, a breakthrough in biomanufacturing that is meant to enable global access and affordability. A division of the company makes and sells animal-component-free cell culture reagents and designs animal-component-free cell culture media formulations for cell-based vaccines, cellular therapies and biomanufacturing.

Website:

www.ventria.com

Ownership Status

Privately Held (no backing)

Financing Status

Corporation

Primary Industry

Pharmaceuticals

Other Industries

Biotechnology

Primary Office

2718 Industrial Drive Junction City, KS 66441United States +1 (800) 916-8311
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Ventria Bioscience's full profile, request a free trial.

Ventria Bioscience Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Ventria Bioscience Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Kansas Bioscience AuthorityGovernment000 0000000 0000
National Institute Of Allergy and Infectious Diseases Extramural ActivitesGovernment000 0000000 0000
National Institutes of HealthGovernment000 0000000 0000
U.S. Department of Health and Human ServicesGovernment000 0000000 0000
Kansas Bioscience Authority Government
National Institute Of Allergy and Infectious Diseases Extramural Activites Government
National Institutes of Health Government
U.S. Department of Health and Human Services Government

Ventria Bioscience Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Scott DeeterPresident, Chief Executive Officer & Board Member
Patrick SmithDirector, Quality Assurance
Randall Alfano Ph.DVice President of InVitria Product Development
Vladimir Akoyev Ph.DVice President of Manufacturing Sciences
Seymour Fein MDChief Medical Officer
Scott Deeter President, Chief Executive Officer & Board Member
Patrick Smith Director, Quality Assurance
Randall Alfano Ph.D Vice President of InVitria Product Development
Vladimir Akoyev Ph.D Vice President of Manufacturing Sciences
Seymour Fein MD Chief Medical Officer

Ventria Bioscience Board Members (5)

NameRepresentingRoleSinceContact
Info
Pablo Valenzuela Ph.DSelfBoard Member000 0000
Scott DeeterVentria BiosciencePresident, Chief Executive Officer & Board Member000 0000
Thomas Urban Jr.SelfBoard Member000 0000
William CrouseSelfBoard Member000 0000
William RutterVentria BioscienceBoard Member000 0000
Pablo Valenzuela Ph.D Board Member Self
Scott Deeter President, Chief Executive Officer & Board Member Ventria Bioscience
Thomas Urban Jr. Board Member Self
William Crouse Board Member Self
William Rutter Board Member Ventria Bioscience
Request full access to PitchBook